Cart
Free US shipping over $10
Proud to be B-Corp

Update on Non-Alcoholic Steatohepatitis, An Issue of Clinics in Liver Disease Summary

Update on Non-Alcoholic Steatohepatitis, An Issue of Clinics in Liver Disease: Volume 27-2 by Zobair M. Younossi (Chairman, Department of Medicine, Inova Fairfax Hospital, Vice President for Research, Inova Health System, Professor of Medicine, VCU-Inova Campus, Beatty Center for Integrated Research)

In this issue, guest editors bring their considerable expertise to this important topic. Contains 20 practice-oriented topics, including metabolic syndrome associated with NASH; genetic markers and comorbidities predisposing to NASH and progressive liver disease; the role of bariatric surgery and endobariatric surgery in NASH; future treatment options and regimens for NAFLD; and more. Provides in-depth clinical reviews on non-alcoholic steatohepatitis, offering actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create clinically significant, topic-based reviews.

Table of Contents

Nonalcoholic Fatty Liver Disease: Disease Burden and Disease Awareness Metabolic Syndrome and Its Association with Nonalcoholic Steatohepatitis Hepatic Outcomes of Nonalcoholic Fatty Liver Disease Including Cirrhosis and Hepatocellular Carcinoma Changings and Challenges in Liver Transplantation for Nonalcoholic Fatty Liver Disease/Steatohepatitis Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Cardiovascular Diseases Extrahepatic Outcomes of Nonalcoholic Fatty Liver Disease: Nonhepatocellular Cancers Update on Nonalcoholic Steatohepatitis: Sarcopenia and Nonalcoholic Fatty Liver Disease Nonalcoholic Fatty Liver Disease in Asia, Africa, and Middle East Region Nonalcoholic Fatty Liver Disease in Latin America and Australia Pathogenetic Pathways in Nonalcoholic Fatty Liver Disease: An Incomplete Jigsaw Puzzle Genetic Markers Predisposing to Nonalcoholic Steatohepatitis Role of Liver Biopsy in Clinical Trials and Clinical Management of Nonalcoholic Fatty Liver Disease Roles of Radiological Tests in Clinical Trials and the Clinical Management of Nonalcoholic Fatty Liver Disease Noninvasive Tests Used in Risk Stratification of Patients with Nonalcoholic Fatty Liver Disease Current Treatment Options, Including Diet, Exercise, and Medications: The Impact on Histology The Role Bariatric Surgery and Endobariatric Therapies in Nonalcoholic Steatohepatitis Future Treatment Options and Regimens for Nonalcoholic Fatty Liver Disease Special Population: Lean Nonalcoholic Fatty Liver Disease Special Population: Pediatric Nonalcoholic Fatty Liver Disease Economic Burden and Patient-Reported Outcomes of Nonalcoholic Fatty Liver Disease Physicians' Use of Digital Health Interventions in the Management of Nonalcoholic fatty liver disease Research Priorities for Precision Medicine in Nonalcoholic fatty liver disease

Additional information

NGR9780323960564
9780323960564
0323960561
Update on Non-Alcoholic Steatohepatitis, An Issue of Clinics in Liver Disease: Volume 27-2 by Zobair M. Younossi (Chairman, Department of Medicine, Inova Fairfax Hospital, Vice President for Research, Inova Health System, Professor of Medicine, VCU-Inova Campus, Beatty Center for Integrated Research)
New
Hardback
Elsevier - Health Sciences Division
2023-04-12
240
N/A
Book picture is for illustrative purposes only, actual binding, cover or edition may vary.
This is a new book - be the first to read this copy. With untouched pages and a perfect binding, your brand new copy is ready to be opened for the first time

Customer Reviews - Update on Non-Alcoholic Steatohepatitis, An Issue of Clinics in Liver Disease